Dark

Check out our Dark Pool Levels

BTCY
BIOTRICITY INC
stock OTC

EOD

Mar 31, 2026

0.2360USD-9.215%(-0.0240)20,454

Pre-market

0.00USD-100.000%(-0.26)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 24, 2022

09:52AM EST Biotricity Receives FDA 510(k) Clearance For Co's Biotres Cardiac Monitoring Device Benzinga

Jan 21, 2022

09:48AM EST Biotricity: Dividend Insights Benzinga

Dec 9, 2021

11:00AM EST Purpose Investments Virtually Opens the Market PR Newswire

Dec 7, 2021

10:38AM EST Biotricity On Nov. 4 Reported Q3 EPS $(0.26), Sales $1.81M Benzinga

Nov 23, 2021

10:17AM EST Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021 Benzinga

06:30AM EST HC Wainwright & Co. Initiates Coverage On Biotricity with Buy Rating, Announces Price Target of $6 Benzinga

Nov 10, 2021

09:45AM EST Biotricity Delivers Bioheart, A Groundbreaking Consumer Heart Monitor Business Wire

Oct 8, 2021

08:16AM EDT Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series Benzinga

Oct 7, 2021

05:15PM EDT EXCLUSIVE: Biotricity CEO On The Co's Cardiac Application Says 'cardiac app will integrate Biotricity's existing and future products, alongside leading industry solutions for fitness and lifestyle, to create a cohesive view of an individual health' Benzinga

Oct 6, 2021

10:42AM EDT Benzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' Show Benzinga

Sep 15, 2021

07:47AM EDT Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring Benzinga

Sep 8, 2021

08:10AM EDT Biotricity To Discuss Sales Expansion, Recent Financing, And Wearable Medical Device Portfolio Expansion At H.C. Wainwright Conference Benzinga

Sep 2, 2021

07:12AM EDT Biotricity Reports Q1 Earnings at 290% for FY2022 Benzinga

Sep 1, 2021

09:06AM EDT Biotricity Uplists to Nasdaq, Poses Significant Buying Opportunity for Investors Benzinga

Aug 30, 2021

06:14PM EDT Biotricity Completes Nasdaq Listing Benzinga

Aug 29, 2021

09:48AM EDT The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week Benzinga

Aug 27, 2021

08:18AM EDT Who is Dr. Waqaas Al-Siddiq, and Why are His Wearables the Most Crucial Devices MedTech Has Ever Seen? Benzinga

08:17AM EDT Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market Benzinga

07:39AM EDT Who is Dr. Waqaas Al-Siddiq, and Why are His Wearables the Most Crucial Devices MedTech Has Ever Seen? Benzinga

Aug 26, 2021

08:09AM EDT The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO Benzinga

Jul 15, 2021

04:18PM EDT Innovative Company Biotricity is Providing Solutions for Chronic Diseases Benzinga

Jul 14, 2021

09:03AM EDT Healthy Hearts and Healthy Wallets: Why one Healthtech Startup is a Must-Invest Benzinga

Jul 1, 2021

05:31PM EDT Why A Northstar Analyst Is Bullish On This Disruptive MedTech Company Benzinga

11:34AM EDT Northland Capital Markets Initiates Coverage On Biotricity with Outperform Rating, Announces Price Target of $7 Benzinga

Jun 30, 2021

09:18AM EDT Improving Cardiac Conditions Through Disruptive Medical Technologies Benzinga

Jun 23, 2021

09:25AM EDT Citius Shows a Promising Future as Share Prices Keep Going up Benzinga

Jun 22, 2021

03:12PM EDT Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021 Benzinga

Jun 2, 2021

08:23AM EDT Lasting Impact of Covid: Fewer Doctor's Office Visits Thanks to At-Home Diagnostics Benzinga

May 18, 2021

12:16PM EDT Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2021 Benzinga

May 6, 2021

12:14PM EDT Maxim Group Is Bullish About Biotricity Generating Over 100% Revenue Growth Benzinga

Apr 20, 2021

09:29AM EDT Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology Benzinga

Mar 25, 2021

02:54PM EDT From BZ Biotech Conference: Biotricity CEO, Founder Dr. Waqaas Al-Siddiq Says Co. Has 100% Re-Order Rate From Doctors, Says Almost 100% Retention Rate Benzinga

02:52PM EDT From BZ Biotech Conference: Biotricity CEO, Founder Dr. Waqaas Al-Siddiq Says COVID-19 Accelerated Awareness In Health, Says Benefited Co. Benzinga

02:47PM EDT From BZ Biotech Conference: Biotricity CEO, Founder Dr. Waqaas Al-Siddiq Says Co. Has Grown Consecutively For 23 Months Benzinga

02:44PM EDT From BZ Biotech Conference: Biotricity CEO, Founder Dr. Waqaas Al-Siddiq Says Real Time Monitoring Acquires More Data, Notes Increased Safety For Patient Benzinga

02:43PM EDT From BZ Biotech Conference: Biotricity CEO, Founder Dr. Waqaas Al-Siddiq Says Most Solutions Are Passively Recording, Says Co.'s Products Are 'Active And Smart'; Says No Need To Ship Recordings Between Patient And Cardiologist Benzinga

02:37PM EDT From BZ Biotech Conference: Biotricity CEO, Founder Dr. Waqaas Al-Siddiq Says Co. Broke First $1M Quarter In Q4 2020 Benzinga

Mar 16, 2021

08:00AM EDT SmallCapVoice.com Inc. (SCV) announces the availability of a new interview with Dr. Waqaas Al-Siddiq, CEO of Biotricity Inc. (OTCQB: BTCY) (the Company), a modern medical technology company delivering disruptive solutions to the multi-billion-dollar cardiac monitoring and diagnostic market. GlobeNewswire Inc

Feb 8, 2021

08:00AM EST Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will discuss the highlights of its financial results for the third quarter of fiscal 2021, ended December 31, 2020, on Thursday, February 11, 2021, after the close of the market. Full financial results will be filed and available on Tuesday February 16, 2021 . GlobeNewswire Inc

Jan 20, 2021

08:00AM EST Biotricity Completes $9.5M of Convertible Promissory Notes to GlobeNewswire Inc

Jan 11, 2021

08:00AM EST Bioheartcomfortably andcontinuously monitors daily activities and providesadvancedheart performance datain a user-friendly format GlobeNewswire Inc

Jan 5, 2021

08:00AM EST BiotricityInc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that itmadea 510(k)submission to the U.S. Food and Drug Administration (FDA),on December 31 2020,forBiotres.The company expects this process totake at least 4 months,and if theCompanys 510(k) application is cleared bythe FDAthe Company expects a product launchthereafter. GlobeNewswire Inc

Dec 9, 2020

08:00AM EST Biotricity to Present at the 13th Annual LD Micro Main Event and GlobeNewswire Inc

Dec 1, 2020

08:00AM EST Biotricity Prepares 510(k) FDA Filing for Biotres GlobeNewswire Inc

Nov 17, 2020

08:00AM EST -- Revenues grow 64.8% over the immediately preceding quarter and a 115.3% increase over the corresponding period of the prior year -- Loss per share of 8.5 cents in line with levels of immediately preceding quarter GlobeNewswire Inc

Nov 12, 2020

08:00AM EST Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today introduced Biocare Telemed, a virtual clinic that provides user-friendly access for patients to receive outstanding medical care and remote patient cardiac monitoring from their physician of choice in the safety and comfort of their home. GlobeNewswire Inc

Sep 29, 2020

08:00AM EDT Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of its Bioflux Direct Program. The new offering ships Bioflux devices directly to at-risk patients who need to self-isolate or avoid in-person clinic visits. GlobeNewswire Inc

Sep 1, 2020

08:01AM EDT Biotricity Provides Quarter Update and Announces Continued Growth GlobeNewswire Inc

Aug 27, 2020

10:53AM EDT Emerging Markets Report: Leaning Into the Opportunity GlobeNewswire Inc

Aug 20, 2020

07:07AM EDT For quite some time followers of remote medical biometric technology company Biotricity (OTCQB: BTCY) have been waiting for news of the Companys anticipated FDA approval for its Bioflux Software II System. GlobeNewswire Inc

Aug 12, 2020

08:00AM EDT Biotricity Signs Agreement with Telemedicine Company GlobeNewswire Inc

Aug 4, 2020

08:00AM EDT Biotricity Inc. (OTCQB BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k) clearance from the FDA for its Bioflux Software II System. GlobeNewswire Inc

Jul 16, 2020

11:35AM EDT Emerging Markets Report: A Gift of Guidance GlobeNewswire Inc

Jul 14, 2020

08:01AM EDT Biotricity Partners with Verizon to Develop EMS Solutions GlobeNewswire Inc

Share